More Than 200 International Cancer Trials Suspended Due to COVID-19 More Than 200 International Cancer Trials Suspended Due to COVID-19

Globally, more than 200 clinical trials have been suspended as a result of factors related to the COVID-19 pandemic.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Related Links:

By RAFAEL FONSECA, MD Reopening safely out of the current pandemic ought to be done via persuasion, not coercion. It has been more than five months since the world first learned about COVID-19. Models predicted a sharp increase in the number of cases, and a seemingly high likelihood the pandemic would overwhelm our hospitals. These models were often inaccurate, and we have all come to learn about the imprecision of epidemiological prediction.  Nevertheless, the infection is far worse than anyone initially accepted – becoming a staple of our generation. Fearing uncountable deaths and the possible need ...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: COVID-19 Health Policy Rafael Fonseca Source Type: blogs
Doctors, scientists and occupational health experts from across the country are openly criticizing the U.S. Environmental Protection Agency’s recent asbestos draft risk evaluation. At a virtual press conference arranged by the Asbestos Disease Awareness Organization last week, speakers labeled the asbestos evaluation inadequate and in need of serious revision. The year-long evaluation was required as part of the Frank R. Lautenberg Chemical Safety for the 21st Century Act, which was passed in 2016. It amended the original Toxic Substances Control Act, the country’s primary chemicals management law. “I am...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Around 2.4m patients are waiting longer for cancer tests or treatment because of 'enormous disruption' to services during the coronavirus pandemic, a charity has warned.
Source: GP Online News - Category: Primary Care Tags: Referrals Source Type: news
More than 24,000 cases of cancer have gone undiagnosed according to Cancer Research UKAlmost 2.5 million Britons have not been screened, tested or treated for cancer because the Covid-19 pandemic has led to “enormous disruption” of NHS care for the disease, experts have warned.More than 24,000 cases of cancer have gone undiagnosed as a result of the suspension of normal services while delays in treatment mean some people ’s disease is now inoperable, Cancer Research UK (CRUK) says.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Cancer Health Society Coronavirus outbreak Science NHS Cancer research UK news Source Type: news
Almost 2.5million patients have missed out on vital cancer tests and treatment because of the pandemic. The NHS faces the shocking backlog of cases as it tries to return to normal.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
(JAMA Network) How the COVID-19 pandemic is associated with national enrollment in cancer clinical trials is investigated in this study.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Publication date: June 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 6Author(s): Afsana Elanko, Jim Khan, Zaed ZR. Hamady, Hassan Malik
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
The novel coronavirus (CoV) pandemic is a serious threat for cancer patients, who have an immunocompromised status, and are considered at high risk for infections. Data on the novel CoV respiratory disease (COVID-19) in cancer patients are still limited. Unlike other common viruses, CoV have not shown to cause a more severe disease in immunocompromised subjects. Along with direct viral pathogenicity, in some individuals CoV infection triggers an uncontrolled aberrant inflammatory response, leading to lung tissue damage.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Original Research Source Type: research
Publication date: Available online 30 May 2020Source: European Journal of Surgical OncologyAuthor(s): R.H. Bhogal, P.H. Patel, S.L.F. Doran, S. Zar, J.M. Pollok, L.R. Jiao, W.H. Allum, M.A. Chaudry, S. Kumar
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | COVID-19 | Health | Hematology | Pandemics